JP2010539101A5 - - Google Patents

Download PDF

Info

Publication number
JP2010539101A5
JP2010539101A5 JP2010524261A JP2010524261A JP2010539101A5 JP 2010539101 A5 JP2010539101 A5 JP 2010539101A5 JP 2010524261 A JP2010524261 A JP 2010524261A JP 2010524261 A JP2010524261 A JP 2010524261A JP 2010539101 A5 JP2010539101 A5 JP 2010539101A5
Authority
JP
Japan
Prior art keywords
compound
formula
salt
converted
converting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010524261A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010539101A (ja
JP5202635B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/076002 external-priority patent/WO2009036161A1/en
Publication of JP2010539101A publication Critical patent/JP2010539101A/ja
Publication of JP2010539101A5 publication Critical patent/JP2010539101A5/ja
Application granted granted Critical
Publication of JP5202635B2 publication Critical patent/JP5202635B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010524261A 2007-09-11 2008-09-11 インテグラーゼ阻害剤の調製のためのプロセスおよび中間体 Expired - Fee Related JP5202635B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97139507P 2007-09-11 2007-09-11
US60/971,395 2007-09-11
PCT/US2008/076002 WO2009036161A1 (en) 2007-09-11 2008-09-11 Process and intermediates for preparing integrase inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013024589A Division JP2013129659A (ja) 2007-09-11 2013-02-12 インテグラーゼ阻害剤の調製のためのプロセスおよび中間体

Publications (3)

Publication Number Publication Date
JP2010539101A JP2010539101A (ja) 2010-12-16
JP2010539101A5 true JP2010539101A5 (cg-RX-API-DMAC7.html) 2012-01-26
JP5202635B2 JP5202635B2 (ja) 2013-06-05

Family

ID=39887255

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010524261A Expired - Fee Related JP5202635B2 (ja) 2007-09-11 2008-09-11 インテグラーゼ阻害剤の調製のためのプロセスおよび中間体
JP2013024589A Withdrawn JP2013129659A (ja) 2007-09-11 2013-02-12 インテグラーゼ阻害剤の調製のためのプロセスおよび中間体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013024589A Withdrawn JP2013129659A (ja) 2007-09-11 2013-02-12 インテグラーゼ阻害剤の調製のためのプロセスおよび中間体

Country Status (20)

Country Link
US (4) US20090099366A1 (cg-RX-API-DMAC7.html)
EP (1) EP2190804B1 (cg-RX-API-DMAC7.html)
JP (2) JP5202635B2 (cg-RX-API-DMAC7.html)
KR (1) KR101488550B1 (cg-RX-API-DMAC7.html)
CN (1) CN101821223B (cg-RX-API-DMAC7.html)
AP (1) AP2785A (cg-RX-API-DMAC7.html)
AR (1) AR068403A1 (cg-RX-API-DMAC7.html)
AU (1) AU2008298943B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0816694A2 (cg-RX-API-DMAC7.html)
CA (1) CA2698245C (cg-RX-API-DMAC7.html)
CO (1) CO6270255A2 (cg-RX-API-DMAC7.html)
EA (1) EA019431B1 (cg-RX-API-DMAC7.html)
ES (1) ES2562080T3 (cg-RX-API-DMAC7.html)
MX (1) MX2010002783A (cg-RX-API-DMAC7.html)
NZ (1) NZ583647A (cg-RX-API-DMAC7.html)
PT (1) PT2190804E (cg-RX-API-DMAC7.html)
TW (1) TWI419867B (cg-RX-API-DMAC7.html)
UA (1) UA101956C2 (cg-RX-API-DMAC7.html)
WO (1) WO2009036161A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201002066B (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1564210T1 (sl) 2002-11-20 2010-01-29 Japan Tobacco Inc 4-oksokinolinske spojine in njihova uporaba kot inhibitorji HIV integraze
CA2847871C (en) * 2005-12-30 2016-07-26 Gilead Sciences, Inc. Methods for improving the pharmacokinetics of hiv integrase inhibitors
AU2007223260C1 (en) 2006-03-06 2011-02-03 Japan Tobacco Inc. Method for producing 4-oxoquinoline compound
WO2007102499A1 (ja) * 2006-03-06 2007-09-13 Japan Tobacco Inc. 4-オキソキノリン化合物の製造方法
HRP20090213B1 (hr) 2006-09-12 2016-12-02 Gilead Sciences, Inc. Postupak i međuprodukti u pripravi inhibitora integraze
JP5547066B2 (ja) * 2007-06-29 2014-07-09 ギリアード サイエンシーズ, インコーポレイテッド 治療用組成物およびその使用
JP5547067B2 (ja) * 2007-06-29 2014-07-09 ギリアード サイエンシーズ, インコーポレイテッド 治療組成物およびその使用
AR068403A1 (es) * 2007-09-11 2009-11-18 Gilead Sciences Inc Proceso e intermediarios para la preparacion de inhibidores de integrasa
WO2011004389A2 (en) 2009-06-18 2011-01-13 Matrix Laboratories Ltd An improved process for the preparation of elvitegravir
CN102212032B (zh) * 2011-04-20 2013-07-31 复旦大学 一种5-羟基喹诺酮类衍生物及其制备方法和用途
US9089574B2 (en) 2011-11-30 2015-07-28 Emory University Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections
AU2013296289B2 (en) * 2012-08-03 2017-10-05 Gilead Sciences, Inc. Process and intermediates for preparing integrase inhibitors
CZ304984B6 (cs) * 2012-10-12 2015-03-11 Zentiva, K.S. Zlepšený způsob výroby a nové intermediáty syntézy elvitegraviru
CZ304983B6 (cs) * 2012-10-12 2015-03-11 Zentiva, K.S. Způsob výroby a nové intermediáty syntézy elvitegraviru
AU2013361401C1 (en) 2012-12-21 2018-08-09 Gilead Sciences, Inc. Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
NO2865735T3 (cg-RX-API-DMAC7.html) 2013-07-12 2018-07-21
EP3019503B1 (en) 2013-07-12 2017-09-06 Gilead Sciences, Inc. Polycyclic-carbamoylpyridone compounds and their use for the treatment of hiv infections
NO2717902T3 (cg-RX-API-DMAC7.html) 2014-06-20 2018-06-23
TW201613936A (en) 2014-06-20 2016-04-16 Gilead Sciences Inc Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
TWI744723B (zh) 2014-06-20 2021-11-01 美商基利科學股份有限公司 多環型胺甲醯基吡啶酮化合物之合成
TWI695003B (zh) 2014-12-23 2020-06-01 美商基利科學股份有限公司 多環胺甲醯基吡啶酮化合物及其醫藥用途
PT3466490T (pt) 2015-04-02 2020-12-24 Gilead Sciences Inc Compostos de carbamoilpiridona policíclicos e sua utilização farmacêutica
CN111733133B (zh) * 2020-07-22 2020-12-01 华夏源(上海)生命科技有限公司 一种促进表皮干细胞分化和生长的方法
CN111944761B (zh) * 2020-08-23 2021-03-26 泉州伟业生物医学科技有限公司 促进表皮干细胞分化和生长的方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1564210A (en) * 1925-12-08 Obin d
DE3501247A1 (de) * 1985-01-16 1986-07-17 Bayer Ag, 5090 Leverkusen Aminoacrylsaeure-derivate
IL155677A0 (en) * 2000-12-14 2003-11-23 Procter & Gamble Cyclization process step in the making of quinolones and naphthyridines
TW200300349A (en) 2001-11-19 2003-06-01 Sankyo Co A 4-oxoqinoline derivative
US20050104233A1 (en) * 2002-05-31 2005-05-19 Shinji Kato Method of substituent introduction through halogen-metal exchange reaction
US6803469B2 (en) * 2002-08-05 2004-10-12 The Procter & Gamble Company Process for preparing quinolone antibiotic intermediates
TW200409759A (en) 2002-09-25 2004-06-16 Wyeth Corp Substituted 4-(indazol-3-yl)phenols
SI1564210T1 (sl) * 2002-11-20 2010-01-29 Japan Tobacco Inc 4-oksokinolinske spojine in njihova uporaba kot inhibitorji HIV integraze
EP1582523A1 (en) 2004-04-02 2005-10-05 Ludwig-Maximilians-Universität München Method of preparing organomagnesium compounds
EP1582524B1 (en) 2004-04-02 2008-08-13 Ludwig Maximilians Universität Method of preparing organomagnesium compounds
MY134672A (en) * 2004-05-20 2007-12-31 Japan Tobacco Inc Stable crystal of 4-oxoquinoline compound
US7531554B2 (en) 2004-05-20 2009-05-12 Japan Tobacco Inc. 4-oxoquinoline compound and use thereof as HIV integrase inhibitor
US8633219B2 (en) 2004-05-21 2014-01-21 Japan Tobacco Inc. Combination therapy
WO2007063869A1 (ja) 2005-11-30 2007-06-07 Japan Tobacco Inc. 高純度キノロン化合物の製造方法
US20090233964A1 (en) * 2005-12-30 2009-09-17 Gilead Sciences, Inc. Methods for improving the pharmacokinetics of hiv integrase inhibitors
AU2007223260C1 (en) 2006-03-06 2011-02-03 Japan Tobacco Inc. Method for producing 4-oxoquinoline compound
WO2007102499A1 (ja) 2006-03-06 2007-09-13 Japan Tobacco Inc. 4-オキソキノリン化合物の製造方法
TW200811153A (en) * 2006-06-23 2008-03-01 Japan Tobacco Inc 6-(heterocyclyl-substituted benzyl)-4-oxoquinoline compound and use thereof as HIV integrase inhibitor
HRP20090213B1 (hr) * 2006-09-12 2016-12-02 Gilead Sciences, Inc. Postupak i međuprodukti u pripravi inhibitora integraze
JP5547066B2 (ja) * 2007-06-29 2014-07-09 ギリアード サイエンシーズ, インコーポレイテッド 治療用組成物およびその使用
JP5547067B2 (ja) * 2007-06-29 2014-07-09 ギリアード サイエンシーズ, インコーポレイテッド 治療組成物およびその使用
AR068403A1 (es) * 2007-09-11 2009-11-18 Gilead Sciences Inc Proceso e intermediarios para la preparacion de inhibidores de integrasa

Similar Documents

Publication Publication Date Title
JP2010539101A5 (cg-RX-API-DMAC7.html)
JP5221544B2 (ja) インテグラーゼ阻害剤を調製するためのプロセスおよび中間体
JP2010503694A5 (cg-RX-API-DMAC7.html)
JP5734207B2 (ja) 亜鉛アミド類の製造及び使用
CA3005738C (en) 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1h-1,2,4-triazol-1-yl)propyl)pyridin-3-yl)oxy)benzonitrile and processes of preparation
JP2012527481A5 (cg-RX-API-DMAC7.html)
JP2010540477A5 (cg-RX-API-DMAC7.html)
JP2010532365A5 (cg-RX-API-DMAC7.html)
JP2007260659A5 (ja) 液相反応用のポリシラン担持遷移金属触媒
JP2013505273A5 (cg-RX-API-DMAC7.html)
JP2011524871A5 (cg-RX-API-DMAC7.html)
JP2008526897A5 (cg-RX-API-DMAC7.html)
JP2006526587A5 (cg-RX-API-DMAC7.html)
TW201040152A (en) Method for preparing ascorbic acid derivatives
JP2018506541A5 (cg-RX-API-DMAC7.html)
JP2011526896A5 (cg-RX-API-DMAC7.html)
US10618868B2 (en) Method for preparing 2-aryl malonamide and applications thereof
JP2013530948A5 (cg-RX-API-DMAC7.html)
JP2020522456A5 (cg-RX-API-DMAC7.html)
RU2013110311A (ru) Синтез соединений тиазолидиндиона
JP6289470B2 (ja) 置換ガンマラクタムの合成方法
JP2008500316A5 (cg-RX-API-DMAC7.html)
JP2011074063A5 (cg-RX-API-DMAC7.html)
JP2014525897A5 (cg-RX-API-DMAC7.html)
JP2017202992A (ja) (トリフルオロメチル)マロン酸エステルの製造方法